Pandemic flu in Russia: special features of a clinical course and the absence of early etiotropic therapy as a risk factor of severe forms of the disease

Pandemic flu in Russia: special features of a clinical course and the absence of early etiotropic therapy as a risk factor of severe forms of the disease

Aim. To assess efficacy and safety of ingavirin in the treatment of the flu caused by pandemic virus of flu A (H1N1) sw1 in hospitalized patients compared with oseltamivir. Material and methods. A population-based comparative multicenter trial included 194 patients with verified diagnosis of the flu...

Full description

Bibliographic Details
Main Authors: Lyudmila Vasil'evna Kolobukhina, L N Merkulova, M Yu Shchelkanov, E I Burtseva, V V Lavrishcheva, E I Samokhvalov, S V Al'khovskiy, A G Prilipov, E S Proshina, S N Avdeev, O A Sutochnikova, M V Bazarova, E I Kelli, N D Tserukalova, I A Blank, O M Shestakova, O N Kolivashko, T V Arseneva, O E Ambrosi, A A Shul'dyakov, A F Popov, A I Simakova, N A Malyshev, A G Chuchalin, D K L'vov, L V Kolobukhina, M Yu Schelkanov, V V Lavrischeva, S V Alkhovsky, A A Shuldyakov, D K Lvov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2011-09-01
Series:Терапевтический архив
Subjects:
flu
pandemia
ingavirin
oseltamivir
treatment efficacy
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/30921

Internet

https://ter-arkhiv.ru/0040-3660/article/view/30921

Similar Items